Sector News

Siegfried buys BASF drug ingredient businesses for $306 million

May 7, 2015
Energy & Chemical Value Chain
(Reuters) – German chemicals group BASF has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding for 270 million euros ($306 million), including assumed debt.
 
“Siegfried will reach the critical size to play a leading role in the supplier market as a recognized partner for the pharmaceutical industry,” said Siegfried Chief Executive Rudolf Hanko.
 
Siegfried said financing of the transaction was secured by a syndicate of Swiss banks and there were no plans for a capital increase. It plans to issue a hybrid bond for partial refinancing after completion of the deal.
 
BASF said on Thursday the move was part of a strategy to focus its pharmaceutical ingredients business on excipients, which are auxiliary pharmaceutical ingredients that help the body to better absorb a drug.
 
BASF will keep selected active ingredients such as ibuprofen, omega-3 fatty acids and polyethylene glycol (PEG), where the company has a leading market position.
 
(Reporting by Ludwig Burger; Editing by Hugh Lawson)

comments closed

Related News

July 21, 2024

PepsiCo and Yara partner to decarbonise European crop production

Energy & Chemical Value Chain

PepsiCo Europe and crop nutrition company Yara have announced a long-term partnership aimed at providing European farmers with low-carbon crop nutrition solutions to help decarbonise the food value chain. Under the agreement, Yara will supply PepsiCo with up to 165,000 tons of fertiliser per year by 2030, covering around 25% of the food and beverage giant’s crop fertiliser needs across Europe.

July 21, 2024

BASF sells Flocculants business for mining applications to Solenis

Energy & Chemical Value Chain

BASF has signed an agreement to sell its flocculants business for mining applications to Solenis, a specialty chemicals manufacturer. The divestment of the flocculants business to Solenis is part of BASF’s ongoing portfolio optimisation with the aim of focusing on strategic core areas.

July 21, 2024

ADAMA announces Gaël Hili as President and CEO replacing Steve Hawkins

Energy & Chemical Value Chain

ADAMA Ltd. a leading crop protection company, announced that its board of directors has appointed Gaël Hili as its President and Chief Executive Officer, effective October 1, 2024. Hili will join the Syngenta Group Leadership Team and will be based in Tel Aviv.

How can we help you?

We're easy to reach